Skip to main content
. 2014 Jun 11;26(7):1711–1720. doi: 10.1681/ASN.2014060588

Table 1.

Conventional diagnoses in 703 biopsies

Conventional Diagnosis All Biopsies (n=703) All Kidneysa (n=564) Kidneys That Did Not Progress to Failure (n=436) Kidneys That Progressed to Failure (n=128) P Valueb (Failed Versus Working)
Rejection-related processes, n (%)
 Pure TCMR 67 (10) 56 (10) 50 (11)a 6 (5) 0.02
 Pure ABMR 110 (16) 94 (17) 47 (11) 47 (37)a <0.001
  C4d-positive ABMR 30 (4) 27 (5) 13 (3) 14 (11)a <0.001
  C4d-negative ABMR 80 (11) 67 (12) 34 (8) 33 (26)a <0.001
 Mixed rejection 28 (4) 12 (2) 8 (2) 4 (3) 0.48
 Borderline 89 (13) 63 (11) 56 (13)a 7 (5) 0.02
 Transplant glomerulopathy 27 (4) 24 (4) 16 (4) 8 (6) 0.20
Other processes, n (%)
 PVN 25 (4) 16 (3) 11 (3) 5 (4) 0.41
 GN 81 (12) 75 (13) 55 (13) 20 (16) 0.38
 Relatively normal 180 (26) 147 (26) 133 (31)a 14 (11)c <0.001
 Atrophy fibrosis of unknown significance 72 (10) 58 (10) 44 (10) 14 (11) 0.78
 Other uncommon diagnosed 24 (3) 19 (3) 16 (4) 3 (2) 0.59
Total 703 564 436 128
a

We selected one random biopsy per kidney. Significant differences in progression to failure highlight that the group is overrepresented in the diagnostic category.

b

Chi-squared and Fisher exact statistical tests.

c

Of 14 failures after a study biopsy that showed relatively normal histology, 8 failures were attributable to late events apparently unrelated to the study biopsy (ABMR, GN, or nonadherence), 3 failures were missed diagnoses of ABMR, and 3 failures have incomplete follow-up records.

d

Other diagnoses included C4d deposition without morphologic evidence for active rejection (n=6), missing diagnosis (n=1), and biopsies with no clear diagnosis, including probable TCMR (n=2), probably normal (n=7), probable atrophy fibrosis of unknown significance (n=5), suspicious for ABMR (n=2), and probable borderline (n=1).